News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
279 Results
Type
Article (29)
Company Profile (1)
Press Release (249)
Section
Business (118)
Career Advice (1)
Deals (25)
Drug Development (29)
FDA (11)
Job Trends (7)
News (167)
Policy (10)
Tag
Alliances (17)
Alzheimer's disease (1)
Approvals (13)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (3)
Cancer (1)
Cardiovascular disease (2)
Clinical research (26)
Collaboration (1)
COVID-19 (2)
Cystic fibrosis (1)
Data (2)
Duchenne muscular dystrophy (1)
Earnings (65)
Events (59)
Executive appointments (1)
FDA (13)
Featured Employer (1)
GLP-1 (1)
Government (2)
Infectious disease (2)
Inflammatory bowel disease (1)
Intellectual property (1)
IPO (16)
Layoffs (3)
Medical device (1)
Medtech (1)
Mergers & acquisitions (10)
Neuroscience (1)
Northern California (3)
Now hiring (1)
Patient recruitment (1)
People (32)
Pharmaceutical (1)
Phase I (5)
Phase II (6)
Phase III (16)
Pipeline (2)
Rare diseases (1)
Real estate (1)
Regulatory (9)
Southern California (7)
Startups (5)
United States (12)
Date
Last 7 days (1)
Last 30 days (6)
Last 365 days (59)
2025 (8)
2024 (62)
2023 (49)
2022 (49)
2021 (46)
2020 (35)
2019 (11)
2018 (4)
2017 (15)
Location
Asia (25)
California (8)
Europe (85)
Japan (8)
New Jersey (1)
Northern California (3)
Pennsylvania (2)
South America (1)
Southern California (7)
Texas (1)
279 Results for "idorsia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Idorsia publishes the resolutions for the upcoming bondholder meeting
February 12, 2025
·
6 min read
Press Releases
Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia
January 16, 2025
·
6 min read
Press Releases
Idorsia provides update on the exclusive negotiations for the global rights to aprocitentan
December 20, 2024
·
7 min read
Press Releases
Idorsia enters into exclusive negotiations for global rights to aprocitentan
November 27, 2024
·
5 min read
Press Releases
Idorsia presents at J.P. Morgan Healthcare Conference 2025 – fighting to create value for all stakeholders
January 16, 2025
·
10 min read
Press Releases
Idorsia announces financial results for the first nine months of 2024
October 29, 2024
·
22 min read
Business
Viatris, Idorsia Ink $350M R&D Pact for Two Phase III Assets
Under the research and development agreement announced Wednesday, Viatris is securing global rights to Idorsia’s late-stage heart and lupus candidates.
February 28, 2024
·
2 min read
·
Tyler Patchen
Business
Idorsia and Viatris enter into a significant global research and development collaboration
Idorsia Ltd announced that it has entered into agreements for a significant global research and development collaboration with Viatris Inc.
February 28, 2024
·
9 min read
Press Releases
Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific Sessions
November 12, 2024
·
5 min read
FDA
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug
Months after Johnson & Johnson turned its back on the hypertension treatment Tryvio, Idorsia has secured the FDA’s nod for the endothelin receptor blocker.
March 21, 2024
·
2 min read
·
Tristan Manalac
1 of 28
Next
